SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-022161
Filing Date
2023-08-04
Accepted
2023-08-04 16:31:05
Documents
16
Period of Report
2023-07-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K arch20230731_8k.htm   iXBRL 8-K 30252
2 EXHIBIT 10.1 ex_552556.htm EX-10.1 21828
3 EXHIBIT 10.2 ex_552580.htm EX-10.2 21760
4 EXHIBIT 10.3 ex_552557.htm EX-10.3 21660
  Complete submission text file 0001437749-23-022161.txt   227890

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA arch-20230731.xsd EX-101.SCH 3409
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arch-20230731_def.xml EX-101.DEF 10353
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE arch-20230731_lab.xml EX-101.LAB 13836
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arch-20230731_pre.xml EX-101.PRE 10348
10 EXTRACTED XBRL INSTANCE DOCUMENT arch20230731_8k_htm.xml XML 2322
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-54986 | Film No.: 231144476
SIC: 3841 Surgical & Medical Instruments & Apparatus